Clinical Trials Browser

Prostatic Neoplasms

NCT07218718 2026-05-22

Oral Cryotherapy to Decrease Taste Changes in Prostate Cancer Patients Receiving Taxane Chemotherapy

Phase NA Recruiting

60 enrolled

Genitourinary

Prostatic Neoplasms

NCT05487846 2026-04-14

Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation

Phase NA Recruiting

120 enrolled

Genitourinary

Prostatic Neoplasms

NCT06422455 2026-03-18

Access to Genetic Testing in Underserved Patients With Cancer

Phase NA Recruiting

800 enrolled

BreastGenitourinaryGynecologic

Breast Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT06855277 2026-02-24

AcTFirst

Phase 3 Recruiting

940 enrolled

Genitourinary

Prostatic Neoplasms

NCT06563388 2026-02-04

ID-COMET

Phase 3 Recruiting

800 enrolled

GastrointestinalGenitourinaryThoracic

Colonic Neoplasms, Lung Neoplasms, Prostatic Neoplasms

NCT06296147 2026-01-16

Virtual Reality Headset and/or Aromatherapy for Patients Undergoing a Transperineal Prostate Biopsy

Phase NA Recruiting

208 enrolled

Genitourinary

Prostatic Neoplasms

NCT05519878 2025-12-24

Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers

Phase NA Recruiting

224 enrolled

Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Prostatic Neoplasms

NCT06046131 2025-11-17

KP-CARAIBES

Phase NA Recruiting

3,000 enrolled

Genitourinary

Adenocarcinoma, Neoplasm Metastasis, Prostatic Neoplasms, Recurrence

NCT05454488 2025-11-14

An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer

Phase 2 Recruiting

30 enrolled

Genitourinary

Prostatic Neoplasms

NCT06014255 2025-10-29

HEAT

Phase 2 Recruiting

219 enrolled

Genitourinary

Prostatic Neoplasms

NCT04751435 2025-10-21

IMAGINE

Phase NA Recruiting

445 enrolled

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT05754658 2025-10-06

African Cancer Genome: GMD

Recruiting

1,500 enrolled

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT07126860 2025-08-17

ZMoveMent-1

Phase NA Recruiting

150 enrolled

Genitourinary

Psychological Well-Being, Motor Activity, Prostatic Neoplasms

NCT06625970 2025-06-26

PEACE 7

Phase 3 Recruiting

700 enrolled

Genitourinary

Prostatic Neoplasms

NCT06636682 2024-10-21

FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer

Phase 2 Recruiting

100 enrolled

Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT04694924 2024-05-22

Prosquare

Recruiting

5,000 enrolled

Genitourinary

Prostatic Neoplasms

NCT05209243 2023-05-19

START-MET

Phase NA Recruiting

266 enrolled

Genitourinary

Prostatic Neoplasms

Clinical Trials

IRONMAN

Oral Cryotherapy to Decrease Taste Changes in Prostate Cancer Patients Receiving Taxane Chemotherapy

Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation

Access to Genetic Testing in Underserved Patients With Cancer

AcTFirst

ID-COMET

Virtual Reality Headset and/or Aromatherapy for Patients Undergoing a Transperineal Prostate Biopsy

Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers

KP-CARAIBES

An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer

HEAT

IMAGINE

African Cancer Genome: GMD

ZMoveMent-1

PEACE 7

FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer

Prosquare

START-MET